☰

Jozsef Toldi - Publications

Affiliations: 
University of Szeged, Szeged, Hungary 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

111/187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tóth F, Fülöp F, Szatmári I, Toldi J, Dékány I, Vécsei L. [Kynurenines and drug research]. Orvosi Hetilap. 161: 443-451. PMID 32172583 DOI: 10.1556/650.2020.31673  0.314
2019 Fehér E, Szatmári I, Dudás T, Zalatnai A, Farkas T, Lőrinczi B, Fülöp F, Vécsei L, Toldi J. Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs. Molecules (Basel, Switzerland). 24. PMID 31561643 DOI: 10.3390/Molecules24193502  0.36
2019 Herédi J, Cseh EK, Berkó AM, Veres G, Zádori D, Toldi J, Kis Z, Vécsei L, Ono E, Gellért L. Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations. Brain Research Bulletin. 146: 185-191. PMID 30639278 DOI: 10.1016/J.Brainresbull.2018.12.014  0.309
2017 Lukács M, Warfvinge K, Tajti J, Fülöp F, Toldi J, Vécsei L, Edvinsson L. Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72). The Journal of Headache and Pain. 18: 39. PMID 28337634 DOI: 10.1186/S10194-017-0746-X  0.354
2017 Herédi J, Veres G, Berkó AM, Vécsei L, Toldi J, Gellért L. S145 Investigating the kynurenine pathway in a novel – In vitro – Model: Possibility for simultaneous biochemical, histological and electrophysiological assessments Clinical Neurophysiology. 128. DOI: 10.1016/J.Clinph.2017.07.156  0.34
2016 Herédi J, Berkó AM, Jankovics F, Iwamori T, Iwamori N, Ono E, Horváth S, Kis Z, Toldi J, Vécsei L, Gellért L. Astrocytic and neuronal localization of kynurenine aminotransferase-2 in the adult mouse brain. Brain Structure & Function. PMID 27568378 DOI: 10.1007/S00429-016-1299-5  0.555
2016 Kocsis K, Frank R, Szabó J, Knapp L, Kis Z, Farkas T, Vécsei L, Toldi J. Acetyl-L-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen-glucose deprivation. Neuroscience. PMID 27378558 DOI: 10.1016/J.Neuroscience.2016.06.046  0.316
2015 Csáti A, Edvinsson L, Vécsei L, Toldi J, Fülöp F, Tajti J, Warfvinge K. Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. The Journal of Headache and Pain. 16: 99. PMID 26627709 DOI: 10.1186/S10194-015-0581-X  0.352
2015 Majláth Z, Török N, Toldi J, Vécsei L. Memantine and kynurenic acid: current neuropharmacological aspects. Current Neuropharmacology. PMID 26564141 DOI: 10.2174/1570159X14666151113123221  0.325
2015 Kassai F, Kedves R, Gyertyán I, Tuka B, Fülöp F, Toldi J, Lendvai B, Vécsei L. Effect of a kynurenic acid analog on home-cage activity and body temperature in rats. Pharmacological Reports : Pr. 67: 1188-92. PMID 26481540 DOI: 10.1016/J.Pharep.2015.04.015  0.321
2015 Tajti J, Majlath Z, Szok D, Csati A, Toldi J, Fulop F, Vecsei L. Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design. Current Pharmaceutical Design. 21: 2250-8. PMID 25557633 DOI: 10.2174/1381612821666150105163055  0.335
2015 Kocsis K, Knapp L, Mészáros J, Kis Z, Farkas T, Vécsei L, Toldi J. Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 867-72. PMID 25432433 DOI: 10.1007/S00702-014-1343-7  0.353
2015 Fejes-Szabó A, Bohár Z, Nagy-Grócz G, Vámos E, Tar L, P?dör B, Tajti J, Toldi J, Vécsei L, Párdutz Á. Effect of probenecid on the pain-related behaviour and morphological markers in orofacial formalin test of the rat. Cns & Neurological Disorders Drug Targets. 14: 350-9. PMID 25106627 DOI: 10.2174/1871527314666150225141229  0.324
2015 Knapp L, Gellért L, Kocsis K, Kis Z, Farkas T, Vécsei L, Toldi J. Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat. Cellular and Molecular Neurobiology. 35: 17-22. PMID 24807461 DOI: 10.1007/S10571-014-0064-7  0.336
2014 Kocsis K, Knapp L, Gellért L, Oláh G, Kis Z, Takakuwa H, Iwamori N, Ono E, Toldi J, Farkas T. Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia. Neuroscience. 269: 265-72. PMID 24704513 DOI: 10.1016/J.Neuroscience.2014.03.055  0.343
2014 Fejes-Szabó A, Bohár Z, Vámos E, Nagy-Grócz G, Tar L, Veres G, Zádori D, Szentirmai M, Tajti J, Szatmári I, Fülöp F, Toldi J, Párdutz Á, Vécsei L. Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 725-38. PMID 24385076 DOI: 10.1007/S00702-013-1146-2  0.354
2013 Oláh G, Herédi J, Menyhárt A, Czinege Z, Nagy D, Fuzik J, Kocsis K, Knapp L, Krucsó E, Gellért L, Kis Z, Farkas T, Fülöp F, Párdutz A, Tajti J, ... ... Toldi J, et al. Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability. Drug Design, Development and Therapy. 7: 981-7. PMID 24068867 DOI: 10.2147/Dddt.S44496  0.381
2013 Gellért L, Knapp L, Németh K, Herédi J, Varga D, Oláh G, Kocsis K, Menyhárt A, Kis Z, Farkas T, Vécsei L, Toldi J. Post-ischemic treatment with L-kynurenine sulfate exacerbates neuronal damage after transient middle cerebral artery occlusion. Neuroscience. 247: 95-101. PMID 23685169 DOI: 10.1016/J.Neuroscience.2013.04.063  0.331
2013 Fuzik J, Gellért L, Oláh G, Herédi J, Kocsis K, Knapp L, Nagy D, Kincses ZT, Kis Z, Farkas T, Toldi J. Fundamental interstrain differences in cortical activity between Wistar and Sprague-Dawley rats during global ischemia. Neuroscience. 228: 371-81. PMID 23103797 DOI: 10.1016/J.Neuroscience.2012.10.042  0.355
2012 Szalardy L, Zadori D, Toldi J, Fulop F, Klivenyi P, Vecsei L. Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Current Topics in Medicinal Chemistry. 12: 1797-806. PMID 23030614 DOI: 10.2174/156802612803989264  0.311
2012 Tajti J, Szok D, Párdutz Á, Tuka B, Csáti A, Kuris A, Toldi J, Vécsei L. Where does a migraine attack originate? In the brainstem. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 557-68. PMID 22426834 DOI: 10.1007/S00702-012-0788-9  0.324
2012 Demeter I, Nagy K, Gellért L, Vécsei L, Fülöp F, Toldi J. A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study : special issue related to kynurenine. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 151-4. PMID 22231843 DOI: 10.1007/S00702-011-0755-X  0.314
2012 Gellért L, Varga D, Ruszka M, Toldi J, Farkas T, Szatmári I, Fülöp F, Vécsei L, Kis Z. Behavioural studies with a newly developed neuroprotective KYNA-amide. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 165-72. PMID 21818601 DOI: 10.1007/S00702-011-0692-8  0.311
2012 Párdutz A, Fejes A, Bohár Z, Tar L, Toldi J, Vécsei L. Kynurenines and headache. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 285-96. PMID 21643792 DOI: 10.1007/S00702-011-0665-Y  0.352
2011 Fejes A, Párdutz A, Toldi J, Vécsei L. Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives. Current Neuropharmacology. 9: 376-87. PMID 22131946 DOI: 10.2174/157015911795596621  0.354
2011 Nagy K, Plangár I, Tuka B, Gellért L, Varga D, Demeter I, Farkas T, Kis Z, Marosi M, Zádori D, Klivényi P, Fülöp F, Szatmári I, Vécsei L, Toldi J. Synthesis and biological effects of some kynurenic acid analogs. Bioorganic & Medicinal Chemistry. 19: 7590-6. PMID 22079867 DOI: 10.1016/J.Bmc.2011.10.029  0.329
2011 Szabó N, Kincses ZT, Toldi J, Vécsei L. Altered tryptophan metabolism in Parkinson's disease: a possible novel therapeutic approach. Journal of the Neurological Sciences. 310: 256-60. PMID 21824629 DOI: 10.1016/J.Jns.2011.07.021  0.309
2011 Nagy D, Kocsis K, Fuzik J, Marosi M, Kis Z, Teichberg VI, Toldi J, Farkas T. Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress. Neuropharmacology. 61: 1026-32. PMID 21781978 DOI: 10.1016/J.Neuropharm.2011.07.005  0.322
2011 Gellért L, Fuzik J, Göblös A, Sárközi K, Marosi M, Kis Z, Farkas T, Szatmári I, Fülöp F, Vécsei L, Toldi J. Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia. European Journal of Pharmacology. 667: 182-7. PMID 21664350 DOI: 10.1016/J.Ejphar.2011.05.069  0.332
2011 Zádori D, Nyiri G, Szonyi A, Szatmári I, Fülöp F, Toldi J, Freund TF, Vécsei L, Klivényi P. Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 865-75. PMID 21194001 DOI: 10.1007/S00702-010-0573-6  0.312
2011 Tajti J, Párdutz A, Vámos E, Tuka B, Kuris A, Bohár Z, Fejes A, Toldi J, Vécsei L. Migraine is a neuronal disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 511-24. PMID 21161301 DOI: 10.1007/S00702-010-0515-3  0.363
2010 Nagy D, Knapp L, Marosi M, Farkas T, Kis Z, Vécsei L, Teichberg VI, Toldi J. Effects of blood glutamate scavenging on cortical evoked potentials. Cellular and Molecular Neurobiology. 30: 1101-6. PMID 20607387 DOI: 10.1007/S10571-010-9542-8  0.367
2010 Marosi M, Nagy D, Farkas T, Kis Z, Rózsa E, Robotka H, Fülöp F, Vécsei L, Toldi J. A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 183-8. PMID 19953278 DOI: 10.1007/S00702-009-0346-2  0.331
2010 Vámos E, Fejes A, Koch J, Tajti J, Fülöp F, Toldi J, Párdutz A, Vécsei L. Kynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changes. Headache. 50: 834-43. PMID 19925620 DOI: 10.1111/J.1526-4610.2009.01574.X  0.363
2009 Vamos E, Pardutz A, Fejes A, Tajti J, Toldi J, Vecsei L. Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus. European Journal of Pharmacology. 621: 33-7. PMID 19744475 DOI: 10.1016/J.Ejphar.2009.08.034  0.368
2009 Vámos E, Párdutz A, Varga H, Bohár Z, Tajti J, Fülöp F, Toldi J, Vécsei L. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacology. 57: 425-9. PMID 19580819 DOI: 10.1016/J.Neuropharm.2009.06.033  0.374
2009 Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. Journal of the Neurological Sciences. 283: 21-7. PMID 19268309 DOI: 10.1016/J.Jns.2009.02.326  0.316
2009 Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L, Teichberg VI, Toldi J. Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cellular and Molecular Neurobiology. 29: 827-35. PMID 19259807 DOI: 10.1007/S10571-009-9364-8  0.358
2009 Marosi M, Fuzik J, Nagy D, Rákos G, Kis Z, Vécsei L, Toldi J, Ruban-Matuzani A, Teichberg VI, Farkas T. Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. European Journal of Pharmacology. 604: 51-7. PMID 19135048 DOI: 10.1016/J.Ejphar.2008.12.022  0.34
2008 Toldi J. Representational plasticity in the mammalian brain cortex. (Review article). Acta Physiologica Hungarica. 95: 229-45. PMID 18788464 DOI: 10.1556/Aphysiol.95.2008.3.1  0.366
2008 Sas K, Robotka H, Rózsa E, Agoston M, Szénási G, Gigler G, Marosi M, Kis Z, Farkas T, Vécsei L, Toldi J. Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiology of Disease. 32: 302-8. PMID 18761090 DOI: 10.1016/J.Nbd.2008.07.013  0.397
2008 Knyihar-Csillik E, Mihaly A, Krisztin-Peva B, Robotka H, Szatmari I, Fulop F, Toldi J, Csillik B, Vecsei L. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Neuroscience Research. 61: 429-32. PMID 18541319 DOI: 10.1016/J.Neures.2008.04.009  0.383
2008 Rozsa E, Robotka H, Nagy D, Farkas T, Sas K, Vecsei L, Toldi J. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study. Brain Research Bulletin. 76: 474-9. PMID 18534254 DOI: 10.1016/J.Brainresbull.2007.12.001  0.362
2008 Rózsa E, Robotka H, Vécsei L, Toldi J. The Janus-face kynurenic acid. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1087-91. PMID 18446262 DOI: 10.1007/S00702-008-0052-5  0.329
2008 Prandovszky E, Horváth S, Gellért L, Kovács SK, Janka Z, Toldi J, Shukla D, Vályi-Nagy T. Nectin-1 (HveC) is expressed at high levels in neural subtypes that regulate radial migration of cortical and cerebellar neurons of the developing human and murine brain. Journal of Neurovirology. 14: 164-72. PMID 18444088 DOI: 10.1080/13550280801898672  0.76
2008 Robotka H, Sas K, Agoston M, Rózsa E, Szénási G, Gigler G, Vécsei L, Toldi J. Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sciences. 82: 915-9. PMID 18387638 DOI: 10.1016/J.Lfs.2008.02.014  0.352
2007 Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Neuroscience. 147: 28-36. PMID 17499931 DOI: 10.1016/J.Neuroscience.2007.04.011  0.341
2007 Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Journal of the Neurological Sciences. 257: 221-39. PMID 17462670 DOI: 10.1016/J.Jns.2007.01.033  0.307
2007 Gigler G, Szénási G, Simó A, Lévay G, Hársing LG, Sas K, Vécsei L, Toldi J. Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. European Journal of Pharmacology. 564: 116-22. PMID 17407777 DOI: 10.1016/J.Ejphar.2007.02.029  0.341
2007 Knyihár-Csillik E, Toldi J, Krisztin-Péva B, Chadaide Z, Németh H, Fenyo R, Vécsei L. Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecid. Neuroscience Letters. 418: 122-6. PMID 17382471 DOI: 10.1016/J.Neulet.2007.03.007  0.397
2007 Knyihár-Csillik E, Toldi J, Mihály A, Krisztin-Péva B, Chadaide Z, Németh H, Fenyo R, Vécsei L. Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 417-21. PMID 16897600 DOI: 10.1007/S00702-006-0545-Z  0.371
2007 Németh H, Robotka H, Toldi J, Vécsei L. Kynurenines in the central nervous system: Recent developments Central Nervous System Agents in Medicinal Chemistry. 7: 45-56. DOI: 10.2174/187152407780059240  0.329
2006 Németh H, Toldi J, Vécsei L. Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies. Journal of Neural Transmission. Supplementum. 285-304. PMID 17017544 DOI: 10.1007/978-3-211-45295-0_45  0.335
2006 Horváth S, Prandovszky E, Kis Z, Krummenacher C, Eisenberg RJ, Cohen GH, Janka Z, Toldi J. Spatiotemporal changes of the herpes simplex virus entry receptor nectin-1 in murine brain during postnatal development. Journal of Neurovirology. 12: 161-70. PMID 16877297 DOI: 10.1080/13550280600760594  0.745
2006 Lür G, Rákos G, Juhász-Vedres G, Farkas T, Kis Z, Toldi J. Effects of dehydroepiandrosterone sulfate on the evoked cortical activity of controls and of brain-injured rats. Cellular and Molecular Neurobiology. 26: 1505-19. PMID 16758322 DOI: 10.1007/S10571-006-9073-5  0.386
2006 Marosi M, Rákos G, Robotka H, Németh H, Sas K, Kis Z, Farkas T, Lür G, Vécsei L, Toldi J. Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia. Journal of Neuroscience Methods. 156: 231-5. PMID 16621009 DOI: 10.1016/J.Jneumeth.2006.03.010  0.323
2006 Juhász-Vedres G, Rózsa E, Rákos G, Dobszay MB, Kis Z, Wölfling J, Toldi J, Párducz A, Farkas T. Dehydroepiandrosterone sulfate is neuroprotective when administered either before or after injury in a focal cortical cold lesion model. Endocrinology. 147: 683-6. PMID 16293666 DOI: 10.1210/En.2005-0693  0.331
2005 Németh H, Toldi J, Vécsei L. Role of kynurenines in the central and peripheral nervous systems. Current Neurovascular Research. 2: 249-60. PMID 16181118 DOI: 10.2174/1567202054368326  0.342
2005 Robotka H, Németh H, Somlai C, Vécsei L, Toldi J. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus. European Journal of Pharmacology. 513: 75-80. PMID 15878711 DOI: 10.1016/J.Ejphar.2005.02.043  0.329
2005 Szegedi V, Fülöp L, Farkas T, Rózsa E, Robotka H, Kis Z, Penke Z, Horváth S, Molnár Z, Datki Z, Soós K, Toldi J, Budai D, Zarándi M, Penke B. Pentapeptides derived from Abeta 1-42 protect neurons from the modulatory effect of Abeta fibrils--an in vitro and in vivo electrophysiological study. Neurobiology of Disease. 18: 499-508. PMID 15755677 DOI: 10.1016/J.Nbd.2004.12.008  0.476
2005 Horváth S, Prandovszky E, Pankotai E, Kis Z, Farkas T, Boldogköi Z, Boda K, Janka Z, Toldi J. Use of a recombinant pseudorabies virus to analyze motor cortical reorganization after unilateral facial denervation. Cerebral Cortex (New York, N.Y. : 1991). 15: 378-84. PMID 15749981 DOI: 10.1093/Cercor/Bhh140  0.755
2004 Németh H, Robotka H, Kis Z, Rózsa E, Janáky T, Somlai C, Marosi M, Farkas T, Toldi J, Vécsei L. Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology. 47: 916-25. PMID 15527825 DOI: 10.1016/J.Neuropharm.2004.06.007  0.323
2004 Kis Z, Rákos G, Farkas T, Horváth S, Toldi J. Facial nerve injury induces facilitation of responses in both trigeminal and facial nuclei of rat. Neuroscience Letters. 358: 223-5. PMID 15039121 DOI: 10.1016/J.Neulet.2004.01.037  0.54
2004 Knyihár-Csillik E, Chadaide Z, Okuno E, Krisztin-Péva B, Toldi J, Varga C, Molnár A, Csillik B, Vécsei L. Kynurenine aminotransferase in the supratentorial dura mater of the rat: effect of stimulation of the trigeminal ganglion. Experimental Neurology. 186: 242-7. PMID 15026260 DOI: 10.1016/J.Expneurol.2003.12.001  0.332
2004 Klivényi P, Toldi J, Vécsei L. Kynurenines in neurodegenerative disorders: therapeutic consideration. Advances in Experimental Medicine and Biology. 541: 169-83. PMID 14977214 DOI: 10.1007/978-1-4419-8969-7_10  0.32
2004 Füvesi J, Somlai C, Németh H, Varga H, Kis Z, Farkas T, Károly N, Dobszay M, Penke Z, Penke B, Vécsei L, Toldi J. Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid. Pharmacology, Biochemistry, and Behavior. 77: 95-102. PMID 14724046 DOI: 10.1016/J.Pbb.2003.10.001  0.377
2003 Farkas T, Racekova E, Kis Z, Horváth S, Burda J, Galik J, Toldi J. Peripheral nerve injury influences the disinhibition induced by focal ischaemia in the rat motor cortex. Neuroscience Letters. 342: 49-52. PMID 12727315 DOI: 10.1016/S0304-3940(03)00230-1  0.578
2002 Kóródi K, Bite A, Borbély E, Kovács G, Nagy A, Süle Z, Toldi J. A combined electrophysiological and behavioural study for the assessment of activity-dependent changes in mice. Acta Biologica Hungarica. 53: 85-94. PMID 12064783 DOI: 10.1556/Abiol.53.2002.1-2.10  0.357
2002 Horváth S, Kis Z, Boldogköi Z, Nógrádi A, Toldi J. Oestrogen-dependent tracing in the rat CNS after pseudorabies virus infection. The European Journal of Neuroscience. 15: 937-43. PMID 11906536 DOI: 10.1046/J.1460-9568.2002.01923.X  0.543
2002 Németh H, Varga H, Farkas T, Kis Z, Vécsei L, Horváth S, Boda K, Wolff JR, Toldi J. Long-term effects of neonatal MK-801 treatment on spatial learning and cortical plasticity in adult rats. Psychopharmacology. 160: 1-8. PMID 11862368 DOI: 10.1007/S00213-001-0957-2  0.647
2001 Kis Z, Budai D, Imre G, Farkas T, Horváth S, Toldi J. The modulatory effect of estrogen on the neuronal activity in the barrel cortex of the rat. An electrophysiological study. Neuroreport. 12: 2509-12. PMID 11496139 DOI: 10.1097/00001756-200108080-00044  0.555
2000 Farkas T, Perge J, Kis Z, Wolff JR, Toldi J. Facial nerve injury-induced disinhibition in the primary motor cortices of both hemispheres. The European Journal of Neuroscience. 12: 2190-4. PMID 10886358 DOI: 10.1046/J.1460-9568.2000.00096.X  0.571
2000 Négyessy L, Gál V, Farkas T, Toldi J. Cross-modal plasticity of the corticothalamic circuits in rats enucleated on the first postnatal day. The European Journal of Neuroscience. 12: 1654-68. PMID 10792443 DOI: 10.1046/J.1460-9568.2000.00057.X  0.391
1999 Kis Z, Horváth S, Hoyk Z, Toldi J, Párducz A. Estrogen effects on arcuate neurons in rat. An in situ electrophysiological study. Neuroreport. 10: 3649-52. PMID 10619660 DOI: 10.1097/00001756-199911260-00034  0.53
1999 Toldi J, Farkas T, Perge J, Wolff JR. Facial nerve injury produces a latent somatosensory input through recruitment of the motor cortex in the rat. Neuroreport. 10: 2143-7. PMID 10424689 DOI: 10.1097/00001756-199907130-00027  0.596
1999 Kis Z, Farkas T, Rábl K, Kis E, Kóródi K, Simon L, Marusin I, Rojik I, Toldi J. Comparative study of the neuronal plasticity along the neuraxis of the vibrissal sensory system of adult rat following unilateral infraorbital nerve damage and subsequent regeneration. Experimental Brain Research. 126: 259-69. PMID 10369148 DOI: 10.1007/S002210050735  0.368
1999 Farkas T, Kis Z, Toldi J, Wolff JR. Activation of the primary motor cortex by somatosensory stimulation in adult rats is mediated mainly by associational connections from the somatosensory cortex. Neuroscience. 90: 353-61. PMID 10215140 DOI: 10.1016/S0306-4522(98)00451-5  0.588
1998 Kóródi K, Toldi J. Does the cortical representation of body parts follow both injury to the related sensory peripheral nerve and its regeneration? Neuroreport. 9: 771-4. PMID 9559954 DOI: 10.1097/00001756-199803090-00038  0.373
1998 Korodi K, Toldi J. Erratum: Does the cortical representation of body parts follow both injury to the related sensory peripheral nerve and its regeneration? (NeuroReport (March 9, 1998) 9:4) Neuroreport. 9. DOI: 10.1097/00001756-199806220-00046  0.313
1997 Farkas T, Rojik I, László F, Varga C, Toldi J. Neuroplastic effects of neonatal capsaicin on barrel cortex of adult rat. An electrophysiological and autoradiographic study European Journal of Neurology. 4: 397-403. DOI: 10.1111/J.1468-1331.1997.Tb00368.X  0.445
1996 Farkas T, Kóródi K, Toldi J. Muscarinic cholinergic effects on stimulus-evoked responses in rat primary somatosensory cortex. An electrophysiological study. Acta Biologica Hungarica. 47: 113-8. PMID 9123984  0.33
1996 Farkas T, Kóródi K, Toldi J. Stimulus-dependent muscarinic effects on evoked unit activity in the rat barrel cortex. Neuroscience Letters. 212: 61-4. PMID 8823763 DOI: 10.1016/0304-3940(96)12784-1  0.421
1996 Toldi J, Laskawi R, Landgrebe M, Wolff JR. Biphasic reorganization of somatotopy in the primary motor cortex follows facial nerve lesions in adult rats. Neuroscience Letters. 203: 179-82. PMID 8742022 DOI: 10.1016/0304-3940(95)12295-8  0.58
1996 Toldi J, Fehér O, Wolff JR. Neuronal plasticity induced by neonatal monocular (and binocular) enucleation. Progress in Neurobiology. 48: 191-218. PMID 8735877 DOI: 10.1016/0301-0082(95)00038-0  0.563
1994 Toldi J, Farkas T, Völgyi B. Neonatal enucleation induces cross-modal changes in the barrel cortex of rat. A behavioural and electrophysiological study. Neuroscience Letters. 167: 1-4. PMID 8177504 DOI: 10.1016/0304-3940(94)91014-6  0.373
1994 Toldi J, Rojik I, Fehér O. Neonatal monocular enucleation-induced cross-modal effects observed in the cortex of adult rat. Neuroscience. 62: 105-14. PMID 7816193 DOI: 10.1016/0306-4522(94)90318-2  0.424
1993 Völgyi B, Farkas T, Toldi J. Compensation of a sensory deficit inflicted upon newborn and adult animals. A behavioural study. Neuroreport. 4: 827-9. PMID 8347832 DOI: 10.1097/00001756-199306000-00058  0.305
1993 Toldi J, Rojik I, Fehér O. Modification in primary visual cortical activity of rat induced by neonatal monocular enucleation, an electrophysiological and autoradiographic study. Acta Physiologica Hungarica. 81: 175-81. PMID 8197873  0.3
1993 Fehér O, Antal A, Toldi J, Wolff JR. Deep sensibility of the mystacial pad in the rat and its cortical representation. Acta Physiologica Hungarica. 81: 121-35. PMID 8197869  0.552
1992 Toldi J, Rojik I, Fehér O. Modification induced in visual cortical activity of rat by neonatal monocular enucleation. Neuroreport. 3: 149-52. PMID 1623163 DOI: 10.1097/00001756-199202000-00007  0.41
1992 Husz T, Joó F, Antal A, Toldi J. Late consequences of cryogenic brain lesion in rat; an electrophysiological study. Neuroreport. 3: 51-4. PMID 1611035 DOI: 10.1097/00001756-199201000-00013  0.334
1992 Wolff JR, Toldi J, Siklós L, Fehér O, Joó F. Neonatal enucleation induces correlated modification in sensory responsive areas and pial angioarchitecture of the parietal and occipital cortex of albino rats. The Journal of Comparative Neurology. 317: 187-94. PMID 1573063 DOI: 10.1002/Cne.903170207  0.589
1992 Toldi J, Joo F, Wolfe JR. Capsaicin differentially influences somatosensory cortical responses evoked by peripheral electrical or mechanical stimulation. Neuroscience. 49: 135-9. PMID 1407542 DOI: 10.1016/0306-4522(92)90081-C  0.591
1990 Toldi J, Feher O, Joo F, Antal A, Wolff JR. Sodium bromide treatment influences the plasticity of somatosensory responses in the rat cortex as induced by enucleation. Neuroscience. 37: 675-83. PMID 2247217 DOI: 10.1016/0306-4522(90)90098-O  0.689
1989 Toldi J, Wolff JR, Wiese UH. Functional consequences of modification of callosal connections by perinatal enucleation in rat visual cortex. Neuroscience. 33: 517-24. PMID 2636705 DOI: 10.1016/0306-4522(89)90403-X  0.581
1989 Párducz A, Toldi J, Joó F, Wolff JR. Inhibition by sodium bromide of synaptic potentiation and calcium accumulation in the superior cervical ganglion of rat. Acta Biologica Hungarica. 40: 221-8. PMID 2633586  0.479
1988 Toldi J, Joo F, Feher O, Wolff JR. Modified distribution patterns of responses in rat visual cortex induced by monocular enucleation. Neuroscience. 24: 59-66. PMID 3368057 DOI: 10.1016/0306-4522(88)90311-9  0.676
1987 Kása P, Toldi J, Farkas Z, Joó F, Wolff JR. Inhibition by sodium bromide of acetylcholine release and synaptic transmission in the superior cervical ganglion of the rat. Neurochemistry International. 11: 443-9. PMID 20501192 DOI: 10.1016/0197-0186(87)90034-9  0.662
1987 Párducz A, Toldi J, Joó F, Siklós L, Wolff JR. Transient increase of calcium in pre- and postsynaptic organelles of rat superior cervical ganglion after tetanizing stimulation. Neuroscience. 23: 1057-61. PMID 3437989 DOI: 10.1016/0306-4522(87)90180-1  0.517
1986 Ambach G, Toldi J, Fehér O, Joó F, Wolff JR. Spatial correlation between sensory regions and the drainage fields of pial veins in rat cerebral cortex. Experimental Brain Research. 61: 540-8. PMID 3956614 DOI: 10.1007/Bf00237579  0.577
1986 Toldi J, Farkas Z, Fehér O, Dames W, Kása P, Gyurkovits K, Joó F, Wolff JR. Promotion by sodium bromide of functional synapse formation from foreign nerves in the superior cervical ganglion of adult rat with intact preganglionic nerve supply. Neuroscience Letters. 69: 19-24. PMID 3748464 DOI: 10.1016/0304-3940(86)90407-6  0.552
1986 Toldi J, Fehér O, Wolff JR. Sensory interactive zones in the rat cerebral cortex. Neuroscience. 18: 461-5. PMID 3736864 DOI: 10.1016/0306-4522(86)90166-1  0.575
1986 Parducz A, Joó F, Toldi J. Formation of synaptic vesicles in the superior cervical ganglion of cat: choline dependency. Experimental Brain Research. 63: 221-4. PMID 3732447 DOI: 10.1007/Bf00235667  0.301
1986 Wolff JR, Joó F, Kása P, Storm-Mathiesen J, Toldi J, Balcar VJ. Presence of neurons with GABA-like immunoreactivity in the superior cervical ganglion of the rat. Neuroscience Letters. 71: 157-62. PMID 3024073 DOI: 10.1016/0304-3940(86)90551-3  0.542
1985 Dames W, Joó F, Fehér O, Toldi J, Wolff JR. gamma-Aminobutyric acid enables synaptogenesis in the intact superior cervical ganglion of the adult rat. Neuroscience Letters. 54: 159-64. PMID 3991056 DOI: 10.1016/S0304-3940(85)80072-0  0.551
1985 Toldi J, Rojik I, Fehér O. The functional projections of the anterior ventralis nucleus, as revealed by autoradiography. Neuroscience Letters. 58: 61-6. PMID 2995874 DOI: 10.1016/0304-3940(85)90329-5  0.363
1984 Toldi J, Fehér O. Acoustic sensitivity and bimodal properties of cells in the anterior suprasylvian gyrus of the cat. Experimental Brain Research. 55: 180-3. PMID 6745348 DOI: 10.1007/Bf00240514  0.308
1984 Toldi J, Fehér O, Feuer L. Dynamic interactions of evoked potentials in a polysensory cortex of the cat. Neuroscience. 13: 645-52. PMID 6527770 DOI: 10.1016/0306-4522(84)90084-8  0.315
1984 Rojik I, Toldi J, Fehér O. Afferent fibers to the anterior suprasylvian gyrus from the medial geniculate body of cat. Neuroscience Letters. 51: 43-6. PMID 6514232 DOI: 10.1016/0304-3940(84)90260-X  0.343
1983 Toldi J, Joó F, Adám G, Fehér O, Wolff JR. Inhibition of synaptic transmission in the rat superior cervical ganglion by intracarotid infusion of bungarotoxin. Brain Research. 262: 323-7. PMID 6301638 DOI: 10.1016/0006-8993(83)91027-2  0.546
1981 Toldi J, Rojik I, Fehér O. Two different polysensory systems in the suprasylvian gyrus of the cat. An electrophysiological and autoradiographic study. Neuroscience. 6: 2539-45. PMID 7322349 DOI: 10.1016/0306-4522(81)90099-3  0.328
Low-probability matches (unlikely to be authored by this person)
1993 Antal A, Bodis-Wollner I, Ghilardi MF, Glover A, Mylin L, Toldi J. The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey. Electroencephalography and Clinical Neurophysiology. 86: 268-74. PMID 7682930 DOI: 10.1016/0013-4694(93)90108-8  0.299
2016 Majláth Z, Toldi J, Fülöp F, Vécsei L. Excitotoxic mechanisms in non-motor dysfunctions and levodopa-induced dyskinesia in Parkinson's disease: the role of the interaction between the dopaminergic and the kynurenine system. Current Medicinal Chemistry. PMID 26872942 DOI: 10.2174/0929867323666160212121915  0.299
2015 Varga D, Herédi J, Kánvási Z, Ruszka M, Kis Z, Ono E, Iwamori N, Iwamori T, Takakuwa H, Vécsei L, Toldi J, Gellért L. Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice. Frontiers in Behavioral Neuroscience. 9: 157. PMID 26136670 DOI: 10.3389/Fnbeh.2015.00157  0.299
2014 Zádori D, Veres G, Szalárdy L, Klivényi P, Toldi J, Vécsei L. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets. Journal of Alzheimer's Disease : Jad. 42: S177-87. PMID 24670398 DOI: 10.3233/Jad-132621  0.299
2009 Zádori D, Klivényi P, Vámos E, Fülöp F, Toldi J, Vécsei L. Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 1403-9. PMID 19618107 DOI: 10.1007/S00702-009-0263-4  0.295
2017 Varga DP, Menyhárt Á, Puskás T, Bari F, Farkas E, Kis Z, Vécsei L, Toldi J, Gellért L. Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice. Microvascular Research. PMID 28546077 DOI: 10.1016/J.Mvr.2017.05.006  0.293
2017 Knapp L, Szita B, Kocsis K, Vécsei L, Toldi J. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues. Drug Design, Development and Therapy. 11: 27-34. PMID 28053504 DOI: 10.2147/Dddt.S117166  0.292
2018 Lajkó E, Tuka B, Fülöp F, Krizbai I, Toldi J, Magyar K, Vécsei L, Kőhidai L. Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29332257 DOI: 10.1007/S00702-018-1839-7  0.292
2015 Török N, Majláth Z, Fülöp F, Toldi J, Vécsei L. Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism. Current Drug Metabolism. PMID 26694727 DOI: 10.2174/1389200217666151222155043  0.288
2006 Szegedi V, Juhász G, Rózsa E, Juhász-Vedres G, Datki Z, Fülöp L, Bozsó Z, Lakatos A, Laczkó I, Farkas T, Kis Z, Tóth G, Soós K, Zarándi M, Budai D, ... Toldi J, et al. Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1191-3. PMID 16636106 DOI: 10.1096/Fj.05-4891Fje  0.286
2015 Bohár Z, Toldi J, Fülöp F, Vécsei L. Changing the face of kynurenines and neurotoxicity: therapeutic considerations. International Journal of Molecular Sciences. 16: 9772-93. PMID 25938971 DOI: 10.3390/Ijms16059772  0.285
2011 Plangár I, Zádori D, Klivényi P, Toldi J, Vécsei L. Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy. Journal of Alzheimer's Disease : Jad. 24: 199-209. PMID 21441658 DOI: 10.3233/Jad-2011-110131  0.285
2017 Lukács M, Tajti J, Fülöp F, Toldi J, Edvinsson L, Vécsei L. Migraine, neurogenic inflammation, drug development - pharmacochemical aspects. Current Medicinal Chemistry. PMID 28707585 DOI: 10.2174/0929867324666170712163437  0.283
2012 Fülöp F, Szatmári I, Toldi J, Vécsei L. Modifications on the carboxylic function of kynurenic acid. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 109-14. PMID 21997444 DOI: 10.1007/S00702-011-0721-7  0.282
2016 Lukács M, Warfvinge K, Kruse LS, Tajti J, Fülöp F, Toldi J, Vécsei L, Edvinsson L. KYNA analogue SZR72 modifies CFA-induced dural inflammation- regarding expression of pERK1/2 and IL-1β in the rat trigeminal ganglion Journal of Headache and Pain. 17. DOI: 10.1186/S10194-016-0654-5  0.281
2018 Hertelendy P, Toldi J, Fulop F, Vecsei L. Ischemic stroke and kynurenines: medicinal chemistry aspects. Current Medicinal Chemistry. PMID 29532751 DOI: 10.2174/0929867325666180313113411  0.279
2012 Hornok V, Bujdosó T, Toldi J, Nagy K, Demeter I, Fazakas C, Krizbai I, Vécsei L, Dékány I. Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 115-21. PMID 22065206 DOI: 10.1007/S00702-011-0726-2  0.277
2010 Kincses ZT, Toldi J, Vécsei L. Kynurenines, neurodegeneration and Alzheimer's disease. Journal of Cellular and Molecular Medicine. 14: 2045-54. PMID 20629991 DOI: 10.1111/J.1582-4934.2010.01123.X  0.276
2012 Korimová A, Cížková D, Toldi J, Vécsei L, Vanický I. Protective effects of glucosamine-kynurenic acid after compression-induced spinal cord injury in the rat Central European Journal of Biology. 7: 996-1004. DOI: 10.2478/S11535-012-0096-2  0.274
2006 Klivenyi P, Bende Z, Hartai Z, Penke Z, Nemeth H, Toldi J, Vecsei L. Behaviour changes in a transgenic model of Huntington's disease. Behavioural Brain Research. 169: 137-41. PMID 16443291 DOI: 10.1016/J.Bbr.2006.01.003  0.274
2008 Robotka H, Toldi J, Vécsei L. L-kynurenine: Metabolism and mechanism of neuroprotection Future Neurology. 3: 169-188. DOI: 10.2217/14796708.3.2.169  0.273
2011 Zádori D, Klivényi P, Plangár I, Toldi J, Vécsei L. Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines. Journal of Cellular and Molecular Medicine. 15: 701-17. PMID 21155972 DOI: 10.1111/J.1582-4934.2010.01237.X  0.273
2010 Sas K, Párdutz A, Toldi J, Vécsei L. Dementia, stroke and migraine--some common pathological mechanisms. Journal of the Neurological Sciences. 299: 55-65. PMID 20828765 DOI: 10.1016/J.Jns.2010.08.001  0.273
2004 Boldogköi Z, Sík A, Dénes A, Reichart A, Toldi J, Gerendai I, Kovács KJ, Palkovits M. Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects. Progress in Neurobiology. 72: 417-45. PMID 15177785 DOI: 10.1016/J.Pneurobio.2004.03.010  0.272
2001 Farkas T, Toldi J. Unmasking of latent synaptic connections in the cortex of the rat, elicited by facial nerve transection Acta Biologica Szegediensis. 45: 51-55.  0.267
2016 Varga N, Csapó E, Majláth Z, Ilisz I, Krizbai IA, Wilhelm I, Knapp L, Toldi J, Vécsei L, Dékány I. Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 86: 67-74. PMID 26924227 DOI: 10.1016/J.Ejps.2016.02.012  0.262
2013 Demeter I, Nagy K, Farkas T, Kis Z, Kocsis K, Knapp L, Gellert L, Fülöp F, Vecsei L, Toldi J. Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study. Neuroscience Letters. 553: 138-41. PMID 23978510 DOI: 10.1016/j.neulet.2013.08.028  0.258
2012 Szalardy L, Klivenyi P, Zadori D, Fulop F, Toldi J, Vecsei L. Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects. Current Medicinal Chemistry. 19: 1899-920. PMID 22429096 DOI: 10.2174/092986712800167365  0.258
2011 Zádori D, Ilisz I, Klivényi P, Szatmári I, Fülöp F, Toldi J, Vécsei L, Péter A. Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog. Journal of Pharmaceutical and Biomedical Analysis. 55: 540-3. PMID 21392919 DOI: 10.1016/J.Jpba.2011.02.014  0.258
2012 Zádori D, Klivényi P, Toldi J, Fülöp F, Vécsei L. Kynurenines in Parkinson's disease: therapeutic perspectives. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 275-83. PMID 21858430 DOI: 10.1007/S00702-011-0697-3  0.255
2020 Tanaka M, Toldi J, Vécsei L. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines. International Journal of Molecular Sciences. 21. PMID 32244523 DOI: 10.3390/Ijms21072431  0.253
1989 Antal A, Toldi J. Cortical potentials evoked by mechanical stimulation of different number of vibrissae of the rat. Acta Biologica Hungarica. 40: 343-53. PMID 2486726  0.253
2017 Tajti J, Szok D, Nagy-Grócz G, Tuka B, Petrovics-Balog A, Toldi J, Vécsei L. Kynurenines and PACAP in migraine: medicinal chemistry and pathogenetic aspects. Current Medicinal Chemistry. PMID 28245765 DOI: 10.2174/0929867324666170227115019  0.248
2014 Zador F, Samavati R, Szlavicz E, Tuka B, Bojnik E, Fulop F, Toldi J, Vecsei L, Borsodi A. Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors. Cns & Neurological Disorders Drug Targets. 13: 1520-9. PMID 25478797 DOI: 10.2174/1871527314666141205164114  0.245
2018 Lukács M, Tajti J, Fülöp F, Toldi J, Edvinsson L, Vécsei L. The therapeutic impact of new migraine discoveries. Current Medicinal Chemistry. PMID 29848264 DOI: 10.2174/0929867325666180530114534  0.242
2015 Szalárdy L, Zádori D, Klivényi P, Toldi J, Vécsei L. Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics. Oxidative Medicine and Cellular Longevity. 2015: 498401. PMID 26301042 DOI: 10.1155/2015/498401  0.238
2016 Majláth Z, Török N, Toldi J, Vécsei L. Promising therapeutic agents for the treatment of Parkinson's disease. Expert Opinion On Biological Therapy. PMID 26961515 DOI: 10.1517/14712598.2016.1164687  0.237
2012 Szabó N, Kincses ZT, Toldi J, Vécsei L. Is Ro 61-8048 a potential fast-acting antidepressant? Journal of the Neurological Sciences. 315: 181-182. DOI: 10.1016/J.Jns.2011.11.036  0.236
2009 Fülöp F, Szatmári I, Vámos E, Zádori D, Toldi J, Vécsei L. Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives. Current Medicinal Chemistry. 16: 4828-42. PMID 19929784 DOI: 10.2174/092986709789909602  0.235
1980 Toldi J, Fehér O. Dynamic interactions of evoked potentials in the association cortex of the cat. Acta Physiologica Academiae Scientiarum Hungaricae. 55: 19-30. PMID 7395529  0.228
2015 Demeter I, Nagy K, Farkas T, Kis Z, Kocsis K, Knapp L, Gellért L, Fülöp F, Vécsei L, Toldi J. Paradox effects of kynurenines on LTP induction. An in vivo study in the Wistar rat. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 47: 75. PMID 26531527 DOI: 10.1016/J.Ijdevneu.2015.04.206  0.226
2010 Oláh G, Nagy D, Marosi M, Farkas T, Kis Z, Párdutz A, Tajti J, Vécsei L, Toldi J. Spreading depression and evoked potentials recorded in the somatosensory cortex of the rat Acta Biologica Szegediensis. 54: 161-164.  0.224
1980 Toldi J, Fehér O, Gerö L. The existence of two polysensory systems in the suprasylvian gyrus of the cat. Acta Physiologica Academiae Scientiarum Hungaricae. 55: 181-7. PMID 7468242  0.208
1985 Toldi J, Fehér O. The role of the gamma-aminobutyrate system in the interactions of cortical evoked potentials. Neuroscience. 15: 977-81. PMID 4047403 DOI: 10.1016/0306-4522(85)90247-7  0.198
1987 Toldi J, Fehér O. Interactions of acoustic and somatosensory evoked responses in a polysensory cortex of the cat. Acta Biologica Hungarica. 38: 333-48. PMID 3503441  0.195
1978 Rojik I, Feher O, Baranyi A, Toldi J. Glycine incorporation into nerve cells parallels cortical activity Neuroscience Letters. 10: S193.  0.193
1984 Toldi J, Fehér O. The properties of acoustically responsive cells in the anterior suprasylvian gyrus of the cat. Acta Physiologica Hungarica. 63: 111-7. PMID 6741560  0.191
2012 Zádori D, Klivényi P, Szalárdy L, Fülöp F, Toldi J, Vécsei L. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders. Journal of the Neurological Sciences. 322: 187-91. PMID 22749004 DOI: 10.1016/J.Jns.2012.06.004  0.185
2012 Füvesi J, Rajda C, Bencsik K, Toldi J, Vécsei L. The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 225-34. PMID 22258797 DOI: 10.1007/s00702-012-0765-3  0.18
2020 Balog E, Jenei G, Gellért L, Ono E, Vécsei L, Toldi J, Kis Z. Species-specific neuronal localization of kynurenine aminotransferase-2 in the mouse cerebellum. Neurochemistry International. 142: 104920. PMID 33238153 DOI: 10.1016/j.neuint.2020.104920  0.177
2014 Knapp L, Gellért L, Herédi J, Kocsis K, Oláh G, Fuzik J, Kis Z, Vécsei L, Toldi J, Farkas T. A simple novel technique to induce short-lasting local brain ischaemia in the rat. Neuropathology and Applied Neurobiology. 40: 603-9. PMID 23795719 DOI: 10.1111/nan.12069  0.159
2014 Obál I, Majláth Z, Toldi J, Vécsei L. Mental disturbances in Parkinson's disease and related disorders: the role of excitotoxins. Journal of Parkinson's Disease. 4: 139-50. PMID 24346238 DOI: 10.3233/JPD-130294  0.158
2007 Rákos G, Kis Z, Nagy D, Lür G, Farkas T, Hortobágyi T, Vécsei L, Toldi J. Evans Blue fluorescence permits the rapid visualization of non-intact cells in the perilesional rim of cold-injured rat brain. Acta Neurobiologiae Experimentalis. 67: 149-54. PMID 17691222  0.151
2013 Vécsei L, Szalárdy L, Fülöp F, Toldi J. Kynurenines in the CNS: recent advances and new questions. Nature Reviews. Drug Discovery. 12: 64-82. PMID 23237916 DOI: 10.1038/nrd3793  0.145
1979 Rojik I, Toldi J, Feher O. Effect of metabolic state on 3H-glycine incorporation in the cat's cortex Acta Physiologica Academiae Scientiarum Hungaricae. 53: 206.  0.145
2014 Majláth Z, Toldi J, Vécsei L. The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 881-9. PMID 24346138 DOI: 10.1007/s00702-013-1135-5  0.139
2016 Zádori D, Veres G, Szalárdy L, Klivényi P, Fülöp F, Toldi J, Vécsei L. Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015). Expert Opinion On Therapeutic Patents. PMID 27172114 DOI: 10.1080/13543776.2016.1189531  0.123
2021 Polyák H, Cseh EK, Bohár Z, Rajda C, Zádori D, Klivényi P, Toldi J, Vécsei L. Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma. Heliyon. 7: e06124. PMID 33553777 DOI: 10.1016/j.heliyon.2021.e06124  0.122
2016 Varga N, Csapó E, Majláth Z, Ilisz I, Krizbai IA, Wilhelm I, Knapp L, Toldi J, Vécsei L, Dékány I. Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles European Journal of Pharmaceutical Sciences. 86: 67-74. DOI: 10.1016/j.ejps.2016.02.012  0.116
2018 Boros FA, Klivényi P, Toldi J, Vécsei L. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease. Expert Opinion On Therapeutic Targets. 1-13. PMID 30449219 DOI: 10.1080/14728222.2019.1549231  0.116
2013 Zádori D, Szalárdy L, Toldi J, Fülöp F, Klivényi P, Vécsei L. Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 673-81. PMID 23196983 DOI: 10.1007/S00702-012-0930-8  0.108
2002 Varga H, Németh H, Tóth T, Kis Z, Farkas T, Toldi J. Weak if any effect of estrogen on spatial memory in rats Acta Biologica Szegediensis. 46: 13-16.  0.098
2009 Simon Z, Ress Z, Toldi J, Trauninger A, Miltényi Z, Illés A. Rare association of Hodgkin lymphoma, Graves' disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility? International Journal of Hematology. 89: 523-8. PMID 19381762 DOI: 10.1007/s12185-009-0281-x  0.097
2021 Annus Á, Tömösi F, Rárosi F, Fehér E, Janáky T, Kecskeméti G, Toldi J, Klivényi P, Sztriha L, Vécsei L. Kynurenic acid and kynurenine aminotransferase are potential biomarkers of early neurological improvement after thrombolytic therapy: A pilot study. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University. 30: 1225-1232. PMID 34637198 DOI: 10.17219/acem/141646  0.096
2015 Majláth ZA, Toldi J, Vécsei L. Chapter 15: The role of the kynurenine pathway in neurodegenerative diseases Targeting the Broadly Pathogenic Kynurenine Pathway. 193-204. DOI: 10.1007/978-3-319-11870-3_15  0.072
2005 Lipták P, Kemény E, Morvay Z, Szederkényi E, Szenohradszky P, Marofka F, Toldi J, Exner M, Iványi B. Peritubular capillary damage in acute humoral rejection: an ultrastructural study on human renal allografts. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5: 2870-6. PMID 16302999 DOI: 10.1111/j.1600-6143.2005.01102.x  0.063
2010 Gárdián G, Sas K, Toldi J, Vécsei L. Protein Misfolding, Mitochondrial Disturbances, And Kynurenines In The Pathogenesis Of Neurodegenerative Disorders Neurovascular Medicine: Pursuing Cellular Longevity For Healthy Aging. DOI: 10.1093/acprof:oso/9780195326697.003.0018  0.05
2014 Kárpáti K, Braunitzer G, Toldi J, Turzó K, Virág K, Reiche WT, Rakonczay Z, Nagy K. Caries and ABO secretor status in a Hungarian population of children and adolescents: an exploratory study. Caries Research. 48: 179-85. PMID 24480885 DOI: 10.1159/000356851  0.043
2015 Majláth ZA, Toldi J, Vécsei L. Chapter 18: The role of kynurenine pathway in pain and migraine Targeting the Broadly Pathogenic Kynurenine Pathway. 233-240. DOI: 10.1007/978-3-319-11870-3_18  0.04
1996 Alkhalifah T, Tsvankin I, Larner K, Toldi J. Velocity analysis and imaging in transversely isotropic media: Methodology and a case study Leading Edge (Tulsa, Ok). 15: 371. DOI: 10.1190/1.1437345  0.033
2004 Jian FX, Larue DK, Castellini A, Toldi JL. Reservoir modeling methods and characterization parameters for a shoreface reservoir: What is important for fluid-flow performance? Spe Reservoir Evaluation and Engineering. 7: 89-104.  0.024
2002 Jian FX, Larue DK, Castellini A, Toldi J. Reservoir Modeling Methods and Characterization Parameters for a Shoreface Reservoir: What is Important for Fluid Flow Performance? Proceedings - Spe Annual Technical Conference and Exhibition. 855-868.  0.024
2001 Toldi J, Gál G. HLA immunization of haemodialysed patients in the transfusion and the erythropoietin eras. Haematologia. 31: 257-61. PMID 11855789 DOI: 10.1163/15685590152763818  0.023
2012 Gresz M, Varga S, Sebestyén A, Toldi J, Bogár L, Molics B, Boncz I. PHP68 The Effect of Resetting the Clock in Health Care Value in Health. 15: A300-A301. DOI: 10.1016/J.JVAL.2012.08.610  0.014
1989 Toldi JL. Velocity analysis without picking Geophysics. 54: 191-199.  0.01
1990 Vesely E, Nemecek P, Toldi J, Rehak J. Computer support of acitivities of the railway service general practitioner Lekar a Technika. 21: K21-K23.  0.01
Hide low-probability matches.